N@N

Andrew Peters Initiated (BIIB) at Strong Buy and Held Target at $315 on, Jun 23rd, 2017

^{Published on 2024-10-25 21:26:07 -}
 

Andrew Peters of Deutsche Bank, Initiated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $315 on, Jun 23rd, 2017.

Andrew has made no other calls on BIIB in the last 4 months.

There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, all agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Carter Gould of "UBS" Upgraded from Strong Sell to Hold on, Monday, June 19th, 2017
• Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Thursday, March 16th, 2017
• Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $305 on, Thursday, March 16th, 2017